Amryt Pharma plc – NASDAQ:AMYT
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Amryt Pharma stock price monthly change
+0.62%
month
Amryt Pharma stock price quarterly change
+105.59%
quarter
Amryt Pharma stock price yearly change
+96.79%
year
Amryt Pharma key metrics
Market Cap | N/A |
Enterprise value | 1.07B |
P/E | 39.73 |
EV/Sales | 4.39 |
EV/EBITDA | 15.39 |
Price/Sales | 3.86 |
Price/Book | 2.90 |
PEG ratio | 0.48 |
EPS | -0.31 |
Revenue | 243.62M |
EBITDA | 1.59M |
Income | -19.96M |
Revenue Q/Q | 8.15% |
Revenue Y/Y | 15.88% |
Profit margin | -8.19% |
Oper. margin | -32.94% |
Gross margin | 47.86% |
EBIT margin | -32.94% |
EBITDA margin | 0.65% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAmryt Pharma stock price history
Amryt Pharma stock forecast
Amryt Pharma financial statements
| Dec 2021 | 54.83M | 22.37M | 40.81% |
|---|---|---|---|
| Mar 2022 | 59.12M | -14.49M | -24.51% |
| Jun 2022 | 68.53M | -7.04M | -10.29% |
| Sep 2022 | 61.12M | -20.79M | -34.02% |
| 2022-05-04 | -0.02 | -0.25 |
|---|---|---|
| 2022-08-04 | -0.06 | -0.17 |
| 2022-11-03 | -0.05 | -0.06 |
| Mar 2022 | 786867000 | 440.88M | 56.03% |
|---|---|---|---|
| Jun 2022 | 764744000 | 422.71M | 55.27% |
| Sep 2022 | 736875000 | 412.59M | 55.99% |
| Apr 2023 | 0 | 0 |
| Dec 2021 | 107.42M | -621K | -116.92M |
|---|---|---|---|
| Mar 2022 | -7.54M | -421K | -2.67M |
| Jun 2022 | -5.95M | -222K | -3.48M |
| Sep 2022 | 14.33M | -16.43M | -5.05M |
Amryt Pharma alternative data
| Aug 2023 | 289 |
|---|---|
| Sep 2023 | 289 |
| Oct 2023 | 289 |
| Nov 2023 | 289 |
| Dec 2023 | 289 |
| Jan 2024 | 289 |
| Feb 2024 | 289 |
| Mar 2024 | 289 |
| Apr 2024 | 289 |
| May 2024 | 289 |
| Jun 2024 | 289 |
| Jul 2024 | 289 |
Amryt Pharma other data
18.28%
+0.10%
of AMYT is owned by hedge funds
45.14M
+255.75K
shares is hold by hedge funds
| Quarter | Transcript |
|---|---|
| Q3 2022 5 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 6 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 8 May 2022 | Q1 2022 Earnings Call Transcript |
| Q4 2021 9 Mar 2022 | Q4 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Joseph A. Wiley (1971) Chief Executive Officer & Director | $1,720,000 |
Mr. Rory P. Nealon (1968) Chief Financial Officer, Chief Operating Officer & Company Sec. | $931,000 |
Krystal Biotech: Reached My Price Target, Waiting For A Drop
Acquisition Of Amryt Pharma: How To Profit From Orphan Drugs Developers
Krystal Biotech: A Buy For Growth Potential
Krystal Biotech: Solid Performance, Let's Keep Holding
Krystal Biotech: High Potential, Buy-At-Dips Stock
Krystal Biotech: The Future Looks More And More Derisked
-
When is Amryt Pharma's next earnings date?
Unfortunately, Amryt Pharma's (AMYT) next earnings date is currently unknown.
-
Does Amryt Pharma pay dividends?
No, Amryt Pharma does not pay dividends.
-
What is Amryt Pharma's stock symbol?
Amryt Pharma plc is traded on the NASDAQ under the ticker symbol "AMYT".
-
What is Amryt Pharma's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Amryt Pharma?
Shares of Amryt Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Amryt Pharma's key executives?
Amryt Pharma's management team includes the following people:
- Dr. Joseph A. Wiley Chief Executive Officer & Director(age: 54, pay: $1,720,000)
- Mr. Rory P. Nealon Chief Financial Officer, Chief Operating Officer & Company Sec.(age: 57, pay: $931,000)
-
How many employees does Amryt Pharma have?
As Jul 2024, Amryt Pharma employs 289 workers.
-
When Amryt Pharma went public?
Amryt Pharma plc is publicly traded company for more then 5 years since IPO on 8 Jul 2020.
-
What is Amryt Pharma's official website?
The official website for Amryt Pharma is amrytpharma.com.
-
How can i contact Amryt Pharma?
Amryt Pharma can be reached via phone at +353 1 518 0200.
Amryt Pharma company profile:
Amryt Pharma plc
amrytpharma.comExchange:
NASDAQ
Full time employees:
289
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
45 Mespil Road
Dublin, 4
Dublin, 4
CIK: 0001783010
:
CUSIP: 03217L106
